• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖而非瘦弱的非糖尿病男性在混合餐或葡萄糖摄入后,肠降血糖素激素的分泌和二肽基肽酶-4 介导的代谢。

Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

机构信息

Department of Clinical Sciences Lund, B11 BMC, SE-2221 84 Lund, Sweden.

出版信息

J Clin Endocrinol Metab. 2010 Feb;95(2):872-8. doi: 10.1210/jc.2009-2054. Epub 2009 Dec 11.

DOI:10.1210/jc.2009-2054
PMID:20008019
Abstract

CONTEXT

Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are cleaved by dipeptidyl peptidase-4 (DPP-4); plasma activity of DPP-4 may be increased in obesity. The impact of this increase on incretin hormone secretion and metabolism is not known.

OBJECTIVE

The aim of the study was to assess incretin hormone secretion and degradation in lean and obese nondiabetic subjects.

DESIGN, SETTINGS, AND PARTICIPANTS: We studied the ingestion of a mixed meal (560 kcal) or oral glucose (2 g/kg) in healthy lean (n = 12; body mass index, 20-25 kg/m(2)) or obese (n = 13; body mass index, 30-35 kg/m(2)) males at a University Clinical Research Unit.

MAIN OUTCOME MEASURES

We measured the area under the curve of plasma intact (i) and total (t) GIP and GLP-1 after meal ingestion and oral glucose.

RESULTS

Plasma DPP-4 activity was higher in the obese subjects (38.5 +/- 3.0 vs. 26.7 +/- 1.6 mmol/min . microl; P = 0.002). Although GIP secretion (AUC(tGIP)) was not reduced in obese subjects after meal ingestion or oral glucose, AUC(iGIP) was lower in obese subjects (8.5 +/- 0.6 vs. 12.7 +/- 0.9 nmol/liter x 300 min; P < 0.001) after meal ingestion. GLP-1 secretion (AUC(tGLP-1)) was reduced in obese subjects after both meal ingestion (7.3 +/- 0.9 vs. 10.0 +/- 0.6 nmol/liter x 300 min; P = 0.022) and oral glucose (6.6 +/- 0.8 vs. 9.6 +/- 1.1 nmol/liter x 180 min; P = 0.035). iGLP-1 was reduced in parallel to tGLP-1.

CONCLUSIONS

  1. Release and degradation of the two incretin hormones show dissociated changes in obesity: GLP-1 but not GIP secretion is lower after meal ingestion and oral glucose, whereas GIP but not GLP-1 metabolism is increased after meal ingestion. 2) Increased plasma DPP-4 activity in obesity is not associated with a generalized augmented incretin hormone metabolism.
摘要

背景

葡萄糖依赖性胰岛素促分泌多肽(GIP)和胰高血糖素样肽-1(GLP-1)可被二肽基肽酶-4(DPP-4)分解;肥胖患者的血浆 DPP-4 活性可能会增加。目前尚不清楚这种增加对肠降血糖素激素分泌和代谢的影响。

目的

本研究旨在评估瘦型和肥胖非糖尿病受试者的肠降血糖素激素分泌和降解情况。

设计、地点和参与者:我们在一所大学临床研究单位研究了健康的瘦型(n = 12;体重指数 20-25 kg/m2)或肥胖型(n = 13;体重指数 30-35 kg/m2)男性进食混合餐(560 千卡)或口服葡萄糖(2 g/kg)后的血浆完整(i)和总(t)GIP 和 GLP-1 曲线下面积。

主要观察指标

我们测量了进食和口服葡萄糖后血浆中 DPP-4 活性、GIP 和 GLP-1 的曲线下面积。

结果

肥胖组的 DPP-4 活性更高(38.5 +/- 3.0 比 26.7 +/- 1.6 mmol/min. microl;P = 0.002)。尽管肥胖组在进食和口服葡萄糖后 GIP 分泌(AUC(tGIP)) 没有减少,但进食后 iGIP 较低(8.5 +/- 0.6 比 12.7 +/- 0.9 nmol/liter x 300 min;P < 0.001)。GLP-1 分泌(AUC(tGLP-1)) 在进食和口服葡萄糖后均减少(7.3 +/- 0.9 比 10.0 +/- 0.6 nmol/liter x 300 min;P = 0.022)(6.6 +/- 0.8 比 9.6 +/- 1.1 nmol/liter x 180 min;P = 0.035)。iGLP-1 与 tGLP-1 平行降低。

结论

1)两种肠降血糖素激素的释放和降解在肥胖中表现出不同的变化:进食和口服葡萄糖后 GLP-1 而非 GIP 分泌减少,而 GIP 而非 GLP-1 代谢增加。2)肥胖时血浆 DPP-4 活性增加并不与普遍增加的肠降血糖素激素代谢相关。

相似文献

1
Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.肥胖而非瘦弱的非糖尿病男性在混合餐或葡萄糖摄入后,肠降血糖素激素的分泌和二肽基肽酶-4 介导的代谢。
J Clin Endocrinol Metab. 2010 Feb;95(2):872-8. doi: 10.1210/jc.2009-2054. Epub 2009 Dec 11.
2
Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.健康男性在标准化餐后上午与下午胰岛及肠促胰岛素激素的差异反应
J Clin Endocrinol Metab. 2009 Aug;94(8):2887-92. doi: 10.1210/jc.2009-0366. Epub 2009 May 12.
3
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.餐后胰岛素和肠促胰岛素激素释放对进餐诱导饱腹感的作用——肥胖与体重减轻的影响
Int J Obes Relat Metab Disord. 2001 Aug;25(8):1206-14. doi: 10.1038/sj.ijo.0801655.
4
Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.通过抑制二肽基肽酶IV来保存活性肠促胰岛素激素可抑制犬餐后肠促胰岛素的分泌。
J Endocrinol. 2002 Feb;172(2):355-62. doi: 10.1677/joe.0.1720355.
5
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.多囊卵巢综合征女性的肠促胰岛素分泌:肥胖、胰岛素敏感性及二甲双胍治疗的作用
Metabolism. 2009 May;58(5):586-93. doi: 10.1016/j.metabol.2008.11.009.
6
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.肥胖患者摄食蛋白质与脂肪对肠降血糖素激素分泌的影响。
Diabetes Obes Metab. 2011 Sep;13(9):863-5. doi: 10.1111/j.1463-1326.2011.01420.x.
7
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.健康受试者以及1型和2型糖尿病患者的肠促胰岛素分泌与进餐量和体重的关系。
J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13. doi: 10.1210/jc.2002-021873.
8
Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.西他列汀对健康瘦素和肥胖人群以及接受或不接受二甲双胍治疗的 2 型糖尿病患者经十二指肠内葡萄糖输注后血糖、肠降血糖素激素和胃十二指肠运动的影响。
Diabetes. 2014 Aug;63(8):2776-87. doi: 10.2337/db13-1627. Epub 2014 Mar 19.
9
Incretin and islet hormonal responses to fat and protein ingestion in healthy men.健康男性中肠促胰岛素和胰岛激素对脂肪及蛋白质摄入的反应。
Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E779-84. doi: 10.1152/ajpendo.90233.2008. Epub 2008 Jul 8.
10
The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.新型即饮乳清蛋白低剂量摄入对中心性肥胖和正常成年男性餐后血糖和激素反应的影响:一项随机对照试验。
Front Endocrinol (Lausanne). 2021 Jun 18;12:696977. doi: 10.3389/fendo.2021.696977. eCollection 2021.

引用本文的文献

1
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.GLP-1 和 NMDA 受体共存于 caveolae 作为治疗神经退行性疾病相关认知功能障碍的创新靶点。
Molecules. 2024 Aug 20;29(16):3922. doi: 10.3390/molecules29163922.
2
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.进食混合宏量营养素餐后,血浆胰高血糖素水平升高与 2 型糖尿病患者和非糖尿病患者的胰岛素清除率降低有关。
Diabetologia. 2024 Nov;67(11):2555-2567. doi: 10.1007/s00125-024-06249-7. Epub 2024 Aug 13.
3
Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants.
肥胖与非肥胖参与者的空腹及餐后胰腺和肠内分泌激素水平。
Peptides. 2024 Jun;176:171186. doi: 10.1016/j.peptides.2024.171186. Epub 2024 Mar 13.
4
The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic -Cell Function and Diabetes.G 蛋白偶联受体和受体激酶在胰腺细胞功能和糖尿病中的作用。
Pharmacol Rev. 2024 Feb 13;76(2):267-299. doi: 10.1124/pharmrev.123.001015.
5
Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review.不同代谢状况下饮食对空腹及刺激后胰高血糖素样肽-1分泌的影响——一篇叙述性综述
Am J Clin Nutr. 2024 Mar;119(3):599-627. doi: 10.1016/j.ajcnut.2024.01.007. Epub 2024 Jan 11.
6
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension.GLP-1 受体激动剂艾塞那肽作为降颅压药物对特发性颅内高压认知功能的影响。
Eye (Lond). 2024 May;38(7):1374-1379. doi: 10.1038/s41433-023-02908-y. Epub 2024 Jan 11.
7
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial.利拉鲁肽对特发性颅内高压的影响:一项随机临床试验。
Brain. 2023 May 2;146(5):1821-1830. doi: 10.1093/brain/awad003.
8
Circadian secretion rhythm of GLP-1 and its influencing factors.GLP-1 的昼夜分泌节律及其影响因素。
Front Endocrinol (Lausanne). 2022 Dec 2;13:991397. doi: 10.3389/fendo.2022.991397. eCollection 2022.
9
Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity-A systematic review and meta-analysis.肥胖人群与非肥胖人群的胃肠激素和食欲评分差异:系统评价和荟萃分析。
Obes Rev. 2023 Feb;24(2):e13531. doi: 10.1111/obr.13531. Epub 2022 Nov 23.
10
The Beneficial Effect of a Healthy Dietary Pattern on Androgen Deprivation Therapy-Related Metabolic Abnormalities in Patients with Prostate Cancer: A Meta-Analysis Based on Randomized Controlled Trials and Systematic Review.健康饮食模式对前列腺癌患者雄激素剥夺治疗相关代谢异常的有益影响:基于随机对照试验的荟萃分析和系统评价
Metabolites. 2022 Oct 13;12(10):969. doi: 10.3390/metabo12100969.